Although the replacement of the human natural crystalline lens by an intraocular lens (IOL), to treat either cataract or Presbyopia is, at present, one of the most commonly performed procedures worldwide, a significant number of patients do not reach optimum vision due to the development of posterior capsule opacification and/or dislocation of the IOL. Through fixOflexTM, EYE PCR incorporates innovation in conjunction with the extraordinarily successful method towards restorative intervention.
A Closer Look at EYE PCR
We thrive at the intersection of innovation and health. Our mission: bring extraordinary science to life-changing therapies for patients with eye disorders. Established in 2018, led by pioneering inventors, EYE PCR ‘s primary objective is to develop a science-based, cutting- edge breakthrough (Peripheral Capsule Reconstruction Torus) that addresses the challenges in cataract and refractive surgery.
fixOflexTM for optimizing
your patients’ IOL performance
Over the past several decades, through improved diagnostic and therapeutic options, cataract extraction and clear lens exchange have been two of the most common surgeries worldwide with significant visual outcomes.
Despite the explosion of innovations designed to improve the quality of vision, several postoperative complications may occur related to the fibrotic reaction and collapse of the lens capsule, that may be the cause of posterior capsule opacification (PCO) and dislocation of the intraocular lens (IOL).
fixOflexTM, circumferential barrier against cell migration and posterior capsule opacification (PCO)
The structures of fixOflexTM’s outer rim maintain contact with the inner peripheral surface of the lens capsule thereby providing a barrier against cell migration.
fixOflexTM, consistent “bed” for IOL placement
fixOflexTM contains stable internal rim structures that fix, centre and stabilise the optical part of the IOL between the anterior and posterior capsular fixed space.
fixOflexTM, secure IOL replacement at any time
By preserving the capsular bag form and enclosed volume, the internal fixed structures of fixOflexTM provide a stable environment for any future IOL replacements.
fixOflexΤΜ has the shape of a torus like structure that includes both stable and flexible parts
EΥΕ PCR Vision
We are Creators of Positive View.
Vision is a valuable gift to which we are committed to safeguard. Through persistent scientific research and our knowledge, we endeavor to provide innovation to the service of patients, significantly improving their everyday lives.
Our vision is to establish a renowned scientific environment building trust by providing science-based, high-tech innovation for the improvement and preservation of our most precious sense.
EΥΕ PCR Vision
est in 2018
A Culture of Innovation
Professor Ioannis Pallikaris has contributed to numerous articles in peer reviewed journals, ophthalmic information magazines and is the author of six books about ophthalmology and innovative techniques. Renowned for his scientific work and dedication in the field of refractive surgery, Professor Ioannis Pallikaris has been honored with twenty-five international awards from the largest associations worldwide, among them the “Barraquer Award” of the AAO American Academy of Ophthalmology, the Redlay Medal of the European Society of Cataract and Refractive Surgery, and others…
We experiment, we research and we invent
We are thinkers and doers. We experiment, we research, and we invent, always evolving and creating results. Collectively, our team forms a solid, cohesive partnership of vastly skilled Ophthalmologists, Engineers and Administrative Specialists, with the expertise, resilience, spirit and professionalism necessary for development against novel targets.
Harilaos S. Ginis, MSc, PhD
Regulatory Affairs Manager
Loukia Leonidou, MSc
Quality Manager /
Manolis Modatsos, MSc
Onurcan Sahin MSc, PhD
Former Product Manager
Stay in touch
If you have any further inquiries about our technology or want to keep in touch with us, please use our contact form and subscribe to our newsletter. We would be more than happy to share with you our latest and excited progress